2015
DOI: 10.1016/j.bmcl.2015.07.025
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
17
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 27 publications
(17 citation statements)
references
References 22 publications
0
17
0
Order By: Relevance
“…The literature devoted to 2‐ethynyl‐4,6‐dimethoxy‐1,3,5‐triazine 1 is extremely scarce . We have recently proved that this dipolarophile constitutes a valuable intermediate in the synthesis of molecules with biological potential . From a synthetic point of view, alkyne 1 is also interesting since the dimethoxytriazine unit has a very pronounced electro‐withdrawing effect and should behave in the same way as classical methyl or ethyl propiolates in cycloaddition reactions.…”
Section: Resultsmentioning
confidence: 99%
“…The literature devoted to 2‐ethynyl‐4,6‐dimethoxy‐1,3,5‐triazine 1 is extremely scarce . We have recently proved that this dipolarophile constitutes a valuable intermediate in the synthesis of molecules with biological potential . From a synthetic point of view, alkyne 1 is also interesting since the dimethoxytriazine unit has a very pronounced electro‐withdrawing effect and should behave in the same way as classical methyl or ethyl propiolates in cycloaddition reactions.…”
Section: Resultsmentioning
confidence: 99%
“…Cycloimmonium salts 4 a‐g and 4 i‐n were obtained as bromides while the 4‐cyanopyridinium salt 4 h was obtained as a chloride. 3,5‐Difluoropyridinium 4 a and 3,5‐dichloropyridinium 4 b salts are not yet described in the literature, while the other intermediate salts 4 c‐n have already been reported …”
Section: Resultsmentioning
confidence: 99%
“…Compound D ) have already been reported as human Polo‐like kinase 1 (PLK1) inhibitors (Figure ). We recently submitted compound E to the NCI cancer screening test and highlighted interesting activities against some cancer cell lines such as SNB‐75 (CNS cancer), 786–0 and RXF 393 (renal cancer) . The standard NCI Compare results indicated that indolizine E may target PLK1 .…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations